Evidence map›Paper›PMID 21727232›Full record

Trial reportThe British journal of psychiatry : the journal of mental science2011

Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder.

Meryl A Butters, Rishi K Bhalla, Carmen Andreescu, Julie Loebach Wetherell, Rose Mantella, Amy E Begley, Eric J Lenze

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The British journal of psychiatry : the journal of mental science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00105586 (Pharmacotherapy of Late-Life Generalized Anxiety Disorder), which is not on this map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00105586 phase4completednot on this map

Pharmacotherapy of Late-Life Generalized Anxiety Disorder

TypeinterventionalSponsorUniversity of PittsburghRan2004 to 2008Enrolled177ConditionsAnxiety Disorders, Generalized Anxiety DisorderArmsEscitalopram
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Anxiety symptoms bias memory assessment in older adults.International journal of geriatric psychiatry · 2017
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Memory in Psychiatric Disorders: A Review.Life (Basel, Switzerland) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Anxiety in late-life depression is associated with poorer performance across multiple cognitive domains.Journal of the International Neuropsychological Society : JINS · 2024
    Article
  13. Article
  14. Article
  15. White Noise-Is Anxiety in Late-Life Associated With White Matter Hyperintensity Burden?The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Meryl A ButtersWestern Psychiatric Institute and Clinic, 3811 O'Hara St, Pittsburgh, PA 15213, USA. buttersma@upmc.edu
Rishi K Bhalla
Carmen Andreescu
Julie Loebach Wetherell
Rose Mantella
Amy E Begley
Eric J Lenze
University of Pittsburgh · USAbbott Fund · USUniversity of British Columbia · CAVA San Diego Healthcare System · USWashington University in St. Louis · US

Funding

MHCRC FOR THE STUDY OF LATE LIFE MOOD DISORDERSP30MH052247 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REYNOLDS, CHARLES F · 1995 to 2004
$7.5M
Pathways Linking Late-Life Depression to MCI &DementiaR01MH072947 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUTTERS, MERYL A · 2005 to 2009
$2.0M
Pharmacotherapy of Latelife Generalized Anxiety DisorderR01MH070547 · NIMH · WASHINGTON UNIVERSITY · PI LENZE, ERIC J · 2005 to 2009
$1.3M
Depression Treatment in Medically Rehabilitating ElderlyK23MH064196 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LENZE, ERIC J · 2001 to 2005
$849k
NIMH NIH HHS K23 MH064196NIMH NIH HHS P30 MH052247NIMH NIH HHS R01 MH070547NIMH NIH HHS R01 MH072947
6 · The paper itself

Abstract

backgroundGeneralised anxiety disorder (GAD) in older adults is associated with neuropsychological impairment. Aims We examined neuropsychological functioning in older adults with GAD in comparison with psychiatrically healthy older adults at baseline, and we examined changes following a 12-week placebo-controlled trial of escitalopram.

methodA total of 160 participants without dementia aged ≥60 with current GAD and 37 individuals in a comparison group without psychiatric history underwent neuropsychological assessment. Of these, 129 participants with GAD were reassessed post-treatment (trial registration: NCT00105586).

resultsThe participants with GAD performed worse than the comparison group in information processing speed, working memory, inhibition, problem-solving (including concept formation and mental flexibility) and immediate and delayed memory. Neuropsychological functioning was correlated with everyday functioning. After treatment, those with low cognitive scores experienced working memory, delayed memory and visuospatial ability improvement and those who reported clinical improvement in anxiety exhibited improvement in the ability to engage inhibition and episodic recall. These improvements were modest and of similar magnitude in both treatment conditions.

conclusionsGeneralised anxiety disorder in older adults is associated with neuropsychological impairments, which are associated with functional impairment. Those with GAD who either have a low cognitive performance or report clinical improvement in anxiety post-treatment, show improvement in multiple cognitive domains. These findings underscore the importance of treatments that aid cognition as well as anxiety symptoms.

Indexed as

AdultAgedAge FactorsAnxiety DisordersAttentionCitalopramCognition DisordersDisability EvaluationFemaleHumansMaleMental ProcessesMiddle AgedNeuropsychological TestsPlacebosPsychiatric Status Rating ScalesCitalopramPlacebosSelective Serotonin Reuptake Inhibitors

Identifiers

PMID21727232
PMCPMC3633554
OpenAlexW2123986082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.